Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle M Watson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|February 22, 2020
Direct Interaction between Calmodulin and the Grb7 RA-PH DomainGabrielle M Watson, Jacqueline A Wilce
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2023
Using Surface Plasmon Resonance to Study SH2 Domain-Peptide InteractionsGabrielle M Watson, Menachem J Gunzburg, Jacqueline A Wilce
Structure (London, England : 1993)|December 12, 2018
Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155Felix A Deuss, Gabrielle M Watson, Zhihui Fu, et al.
Frontiers in Molecular Biosciences|October 12, 2017
Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain TargetGabrielle M Watson, William A H Lucas, Menachem J Gunzburg, et al.
Nature Reviews. Immunology|November 1, 2019
Modulation of innate and adaptive immunity by cytomegalovirusesRichard Berry, Gabrielle M Watson, Stipan Jonjic, et al.
Biochemical Society Transactions|December 1, 2020
A pocket guide on how to structure SARS-CoV-2 drugs and therapiesDene R Littler, Bruce J MacLachlan, Gabrielle M Watson, et al.
ACS Omega|November 21, 2017
Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting PeptideGabrielle M Watson, Ketav Kulkarni, Rebecca Brandt, et al.
Journal of Medicinal Chemistry|October 31, 2017
Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer TargetGabrielle M Watson, Ketav Kulkarni, Jianrong Sang, et al.
Biomedicines|May 28, 2022
Enhancing the Bioactivity of Bicyclic Peptides Targeted to Grb7-SH2 by Restoring Cell PermeabilityNatasha P Sturre, Rhys N Colson, Neelam Shah, et al.
Molecules (Basel, Switzerland)|October 20, 2019
Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular ActivityJianrong Sang, Ketav Kulkarni, Gabrielle M Watson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|February 22, 2020
Direct Interaction between Calmodulin and the Grb7 RA-PH DomainGabrielle M Watson, Jacqueline A Wilce
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2023
Using Surface Plasmon Resonance to Study SH2 Domain-Peptide InteractionsGabrielle M Watson, Menachem J Gunzburg, Jacqueline A Wilce
Structure (London, England : 1993)|December 12, 2018
Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155Felix A Deuss, Gabrielle M Watson, Zhihui Fu, et al.
Frontiers in Molecular Biosciences|October 12, 2017
Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain TargetGabrielle M Watson, William A H Lucas, Menachem J Gunzburg, et al.
Nature Reviews. Immunology|November 1, 2019
Modulation of innate and adaptive immunity by cytomegalovirusesRichard Berry, Gabrielle M Watson, Stipan Jonjic, et al.
Biochemical Society Transactions|December 1, 2020
A pocket guide on how to structure SARS-CoV-2 drugs and therapiesDene R Littler, Bruce J MacLachlan, Gabrielle M Watson, et al.
ACS Omega|November 21, 2017
Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting PeptideGabrielle M Watson, Ketav Kulkarni, Rebecca Brandt, et al.
Journal of Medicinal Chemistry|October 31, 2017
Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer TargetGabrielle M Watson, Ketav Kulkarni, Jianrong Sang, et al.
Biomedicines|May 28, 2022
Enhancing the Bioactivity of Bicyclic Peptides Targeted to Grb7-SH2 by Restoring Cell PermeabilityNatasha P Sturre, Rhys N Colson, Neelam Shah, et al.
Molecules (Basel, Switzerland)|October 20, 2019
Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular ActivityJianrong Sang, Ketav Kulkarni, Gabrielle M Watson, et al.
Pageof 2